2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine

C150H216N46O12 — CID 163646584

IUPAC2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine
SMILESCOc1cc2c(NCN3CCNCC3)nc(-n3ccc4ccccc43)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cccn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3ccnc3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cncn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCC3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCCCC3)nc2cc1OCCCN1CCCC1
InChIInChI=1S/C29H37N7O2.C26H41N7O2.2C24H34N8O2.C24H37N7O2.C23H33N9O2/c1-37-26-19-23-24(20-27(26)38-18-6-14-34-12-4-5-13-34)32-29(36-15-9-22-7-2-3-8-25(22)36)33-28(23)31-21-35-16-10-30-11-17-35;1-34-23-18-21-22(19-24(23)35-17-7-12-31-10-5-6-11-31)29-26(33-13-3-2-4-14-33)30-25(21)28-20-32-15-8-27-9-16-32;1-33-21-15-19-20(16-22(21)34-14-4-10-30-8-2-3-9-30)28-24(32-13-7-26-17-32)29-23(19)27-18-31-11-5-25-6-12-31;1-33-21-16-19-20(17-22(21)34-15-5-11-30-9-2-3-10-30)28-24(32-12-4-6-27-32)29-23(19)26-18-31-13-7-25-8-14-31;1-32-21-16-19-20(17-22(21)33-15-5-10-29-8-2-3-9-29)27-24(31-11-4-12-31)28-23(19)26-18-30-13-6-25-7-14-30;1-33-20-13-18-19(14-21(20)34-12-4-9-30-7-2-3-8-30)28-23(32-16-25-15-27-32)29-22(18)26-17-31-10-5-24-6-11-31/h2-3,7-9,15,19-20,30H,4-6,10-14,16-18,21H2,1H3,(H,31,32,33);18-19,27H,2-17,20H2,1H3,(H,28,29,30);7,13,15-17,25H,2-6,8-12,14,18H2,1H3,(H,27,28,29);4,6,12,16-17,25H,2-3,5,7-11,13-15,18H2,1H3,(H,26,28,29);16-17,25H,2-15,18H2,1H3,(H,26,27,28);13-16,24H,2-12,17H2,1H3,(H,26,28,29)
InChIKeyIISSNLAIGMGOHH-UHFFFAOYSA-N
MW2855.69 g/mol
LogP13.76
Rot. Bonds60

About 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine

2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine (PubChem CID 163646584) has the molecular formula C150H216N46O12 and a molecular weight of 2855.69 g/mol. Its IUPAC name is 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine.

Molecular Properties

Compound Name2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine
PubChem CID163646584
Molecular FormulaC150H216N46O12
Molecular Weight2855.69 g/mol
Exact Mass2853.77
IUPAC Name2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine
SMILESCOc1cc2c(NCN3CCNCC3)nc(-n3ccc4ccccc43)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cccn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3ccnc3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cncn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCC3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCCCC3)nc2cc1OCCCN1CCCC1
InChIInChI=1S/C29H37N7O2.C26H41N7O2.2C24H34N8O2.C24H37N7O2.C23H33N9O2/c1-37-26-19-23-24(20-27(26)38-18-6-14-34-12-4-5-13-34)32-29(36-15-9-22-7-2-3-8-25(22)36)33-28(23)31-21-35-16-10-30-11-17-35;1-34-23-18-21-22(19-24(23)35-17-7-12-31-10-5-6-11-31)29-26(33-13-3-2-4-14-33)30-25(21)28-20-32-15-8-27-9-16-32;1-33-21-15-19-20(16-22(21)34-14-4-10-30-8-2-3-9-30)28-24(32-13-7-26-17-32)29-23(19)27-18-31-11-5-25-6-12-31;1-33-21-16-19-20(17-22(21)34-15-5-11-30-9-2-3-10-30)28-24(32-12-4-6-27-32)29-23(19)26-18-31-13-7-25-8-14-31;1-32-21-16-19-20(17-22(21)33-15-5-10-29-8-2-3-9-29)27-24(31-11-4-12-31)28-23(19)26-18-30-13-6-25-7-14-30;1-33-20-13-18-19(14-21(20)34-12-4-9-30-7-2-3-8-30)28-23(32-16-25-15-27-32)29-22(18)26-17-31-10-5-24-6-11-31/h2-3,7-9,15,19-20,30H,4-6,10-14,16-18,21H2,1H3,(H,31,32,33);18-19,27H,2-17,20H2,1H3,(H,28,29,30);7,13,15-17,25H,2-6,8-12,14,18H2,1H3,(H,27,28,29);4,6,12,16-17,25H,2-3,5,7-11,13-15,18H2,1H3,(H,26,28,29);16-17,25H,2-15,18H2,1H3,(H,26,27,28);13-16,24H,2-12,17H2,1H3,(H,26,28,29)
InChIKeyIISSNLAIGMGOHH-UHFFFAOYSA-N
XLogP13.76
TPSA526.44 Ų
H-Bond Donors12
H-Bond Acceptors58
Rotatable Bonds60
Heavy Atoms208
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002855.69
LogP ≤ 513.76
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1058

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine?
The IUPAC name of 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine (CID 163646584) is 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine.
What is the SMILES notation for 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine?
The canonical SMILES for 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine is COc1cc2c(NCN3CCNCC3)nc(-n3ccc4ccccc43)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cccn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3ccnc3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(-n3cncn3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCC3)nc2cc1OCCCN1CCCC1.COc1cc2c(NCN3CCNCC3)nc(N3CCCCC3)nc2cc1OCCCN1CCCC1.
What is the InChIKey of 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine?
The InChIKey is IISSNLAIGMGOHH-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H37N7O2.C26H41N7O2.2C24H34N8O2.C24H37N7O2.C23H33N9O2/c1-37-26-19-23-24(20-27(26)38-18-6-14-34-12-4-5-13-34)32-29(36-15-9-22-7-2-3-8-25(22)36)33-28(23)31-21-35-16-10-30-11-17-35;1-34-23-18-21-22(19-24(23)35-17-7-12-31-10-5-6-11-31)29-26(33-13-3-2-4-14-33)30-25(21)28-20-32-15-8-27-9-16-32;1-33-21-15-19-20(16-22(21)34-14-4-10-30-8-2-3-9-30)28-24(32-13-7-26-17-32)29-23(19)27-18-31-11-5-25-6-12-31;1-33-21-16-19-20(17-22(21)34-15-5-11-30-9-2-3-10-30)28-24(32-12-4-6-27-32)29-23(19)26-18-31-13-7-25-8-14-31;1-32-21-16-19-20(17-22(21)33-15-5-10-29-8-2-3-9-29)27-24(31-11-4-12-31)28-23(19)26-18-30-13-6-25-7-14-30;1-33-20-13-18-19(14-21(20)34-12-4-9-30-7-2-3-8-30)28-23(32-16-25-15-27-32)29-22(18)26-17-31-10-5-24-6-11-31/h2-3,7-9,15,19-20,30H,4-6,10-14,16-18,21H2,1H3,(H,31,32,33);18-19,27H,2-17,20H2,1H3,(H,28,29,30);7,13,15-17,25H,2-6,8-12,14,18H2,1H3,(H,27,28,29);4,6,12,16-17,25H,2-3,5,7-11,13-15,18H2,1H3,(H,26,28,29);16-17,25H,2-15,18H2,1H3,(H,26,27,28);13-16,24H,2-12,17H2,1H3,(H,26,28,29).
What are the key properties of 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine?
2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine has a molecular weight of 2855.69 g/mol, XLogP of 13.76, 60 rotatable bonds, 12 hydrogen bond donors, and 58 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(azetidin-1-yl)-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-imidazol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;2-indol-1-yl-6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-piperidin-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-2-pyrazol-1-yl-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine;6-methoxy-N-(piperazin-1-ylmethyl)-7-(3-pyrrolidin-1-ylpropoxy)-2-(1,2,4-triazol-1-yl)quinazolin-4-amine is sourced from PubChem (CID 163646584), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).